GlaxoSmithKline PLC Equity Dashboard

<div class='circular--portrait' style='background:#754DEB;color: #F0FFF0;font-size:4em;padding-top: 25px;;'>GP</div>
GSK -- USA Stock  

Report: 22nd of July 2020  

The GlaxoSmithKline PLC Equities Center is a collection of modules for GlaxoSmithKline PLC equity research and analysis. Using equity center you examine different market driven as well as company-specific characteristics using powerful technical, fundamental, predictive and other GlaxoSmithKline PLC specific modules. Please select from the options below.
This is a quick snapshot of GlaxoSmithKline PLC research areas. You can expand your research by examining different market driven as well as company-specific characteristics using powerful cross-assets modules such as watchlist analyzer, correlation inspector, opportunity browser, portfolio optimizer and and many other powerfull tools.
Quote & Profile

Quote & Profile

GlaxoSmithKline PLC profile, quote, and daily performance
Earnings Estimate

Earnings Estimate

Historical and projected earnings estimates for GlaxoSmithKline PLC
Updated
Fundamental Analysis

Fundamental Analysis

Fundamentals and financial ratios for GlaxoSmithKline PLC
Event Calendar

Event Calendar

Calendar of corporate events and headlines for GlaxoSmithKline PLC
Updated
Technical Analysis

Technical Analysis

Basic technical indicators and analysis for GlaxoSmithKline PLC
Momentum Indicators

Momentum Indicators

View over 20 different momentum indicators for GlaxoSmithKline PLC
Updated
Alpha Analysis

Alpha Analysis

Instant market alpha and beta exploration for GlaxoSmithKline PLC
Chance of Bankruptcy

Chance of Bankruptcy

GlaxoSmithKline PLC chance of financial distress in the next 2 years
Pattern Recognition

Pattern Recognition

View over 30 different GlaxoSmithKline PLC historical pattern-recognition indicators
Current Valuation

Current Valuation

GlaxoSmithKline PLC valuation after adjusting for liquid asset and debt
News and Headlines

News and Headlines

GlaxoSmithKline PLC current and past headlines and price impact
Bollinger Bands

Bollinger Bands

Analyze GlaxoSmithKline PLC Bollinger Bands indicator to determine target price movement boundaries
Historical Volatility

Historical Volatility

GlaxoSmithKline PLC volatility and risk analysis compared to market
Updated
Correlation With Market

Correlation With Market

GlaxoSmithKline PLC correlation with market
Backtesting

Backtesting

Backtesting to check gain and loss over specified period
Compare to peers

Compare to peers

GlaxoSmithKline PLC in the context of related companies
Management

Management

GlaxoSmithKline PLC leadership and management evaluation
Performance

Performance

Risk-adjusted expected returns and performance analysis
Risk-adjusted Recommendation

Risk-adjusted Recommendation

Personalized buy or sell advice on GlaxoSmithKline PLC
Power Widgets

Power Widgets

Macroaxis widgets syndication for GlaxoSmithKline PLC
Price Prediction

Price Prediction

Basic GlaxoSmithKline PLC price forecast based on headlines and hype
Updated
Analyst Recommendations

Analyst Recommendations

Analyst recommendations and target price estimates for GlaxoSmithKline PLC
Piotroski F Score

Piotroski F Score

Piotroski F Score is based on binary analysis strategy of GlaxoSmithKline PLC
Fundamental History

Fundamental History

GlaxoSmithKline PLC history of fundamentals from various financial
Revenue

Revenue

Relative GlaxoSmithKline PLC revenue analysis
Updated
Net Income Analysis

Net Income Analysis

GlaxoSmithKline PLC income analysis for the latest period
Financial Leverage

Financial Leverage

Effects of financial leverage on GlaxoSmithKline PLC operations
Balance Of Power

Balance Of Power

Daily balance of power indicator of GlaxoSmithKline PLC
Semi-Deviation

Semi-Deviation

Current Semi-Deviation of GlaxoSmithKline PLC
Price History

Price History

GlaxoSmithKline PLC daily price history and news impact
Updated
Pair Correlation

Pair Correlation

Correlation between GlaxoSmithKline PLC and Grifols S
GSK vs. NVS

GSK vs. NVS

Fundamentals comparison between GlaxoSmithKline PLC and Novartis
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page